Domperidone PCD Pharma Franchise Company

Cafoli Lifecare offers a large Domperidone range of 34 formulations across tablets, capsules, oral drops and suspension, manufactured in WHO-GMP certified facilities. Distributors building a gastro-intestinal portfolio can secure district-wise monopoly franchise rights across this everyday prokinetic with full promotional support.

What is Domperidone?

Domperidone is a dopamine antagonist that acts as a prokinetic and anti-emetic. It speeds gastric emptying and increases upper-gut motility while blocking the vomiting trigger zone, relieving nausea, vomiting, bloating and reflux. It is very widely combined with proton-pump inhibitors. Reference: PubChem - Domperidone.

Available Forms

The Cafoli Domperidone portfolio spans oral Tablets and Capsules (extensively combined with omeprazole, pantoprazole, rabeprazole and esomeprazole), paediatric Drops and Suspension. Contact us for current pack presentations and combinations.

Therapeutic Applications

Domperidone is prescribed for nausea and vomiting, gastro-oesophageal reflux and dyspepsia, gastroparesis, bloating and functional gut motility disorders. Prescribers include gastroenterologists, physicians, paediatricians and general practitioners.

Why Domperidone is a High-Potential Molecule for Distributors

Acidity, reflux and nausea are everyday complaints, and domperidone-PPI combinations are among the highest-volume prescriptions in India, written across virtually every specialty. Its huge combination and paediatric range lets a distributor cover the whole acid-peptic and anti-emetic market from one molecule, making it a core volume driver.

Why Choose Cafoli Lifecare

Cafoli Lifecare offers monopoly franchise rights, WHO-GMP certified manufacturing, DCGI-approved formulations, a network of 1000+ franchise partners across India, and free promotional inputs.

References

1. PubChem: Domperidone
2. MedlinePlus: Gastro-oesophageal reflux
3. PubMed: domperidone as prokinetic anti-emetic